Navigation Links
Varian, Inc. Announces First Quarter 2009 Preliminary Results
Date:1/16/2009

PALO ALTO, Calif., Jan. 16 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) today announced preliminary results for the first quarter of its fiscal year 2009, which ended January 2, 2009.

First quarter sales should be between $205 million and $210 million. Non- GAAP (adjusted) diluted earnings per share should be between $0.50 and $0.54 including share-based compensation expense of approximately $0.05. On a GAAP basis, diluted earnings per share should be between $0.41 and $0.45. Adjusted operating margins should be between 11.2% and 11.4% in the quarter, while GAAP operating margins should be between 9.4% and 9.6%. Operating cash flow should be between $15 million and $20 million for the quarter.

For a complete reconciliation of non-GAAP (adjusted) financial information used in this press release to the most directly comparable GAAP financial information, please refer to the attached Reconciliations of GAAP to Adjusted Results, Preliminary.

Sales were below expectations in the first quarter primarily due to lower revenues from research products (in particular NMR and imaging systems). Despite order weakness late in the quarter, in particular for certain vacuum and analytical products, total company orders exceeded sales for the quarter. Adjusted operating margins held up well, even on lower revenues, due to the positive impact of efficiency improvements implemented in recent years and favorable foreign currency movements. In addition, operating cash flow was solid during the quarter.

"With respect to our research products sales, we have said many times that the timing of revenues on these products is impacted by factors such as laboratory readiness and access to customer sites, duration of installations and availability of key components and installation personnel," said Garry W. Rogerson, President and Chief Executive Officer. "Although we entered the first quart
'/>"/>

SOURCE Varian, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Varian, Inc. Announces Cost Reduction Plan
2. Varian, Inc. Announces Online Experience
3. Varian, Inc. CEO to Speak at the Nasdaq OMX 22nd Investor Program
4. Varian, Inc. Reports Strong Fourth Quarter 2008 Results
5. New Flexible Vacuum Controller from Varian, Inc. is Expandable and Easy to Use
6. Varian, Inc. Board of Directors Makes Officer Changes
7. Varian, Inc. to Present at Thomas Weisel Partners 2008 Healthcare Conference
8. New Dual Wavelength X-ray Diffractometer From Oxford Diffraction, Now a Part of Varian, Inc., Allows Increased Throughput for Challenging Single Crystal Analyses
9. New Turbomolecular Pumping System From Varian, Inc. Delivers Portable, Dry, Ultra-high Vacuum.
10. Varian, Inc. Reports Third Quarter 2008 Results
11. James T. Glover Appointed to Board of Directors of Varian, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Sept. 17, 2014 Hussey Copper , ... 29 antimicrobial copper, announces Gilmour Academy Ice Arena,s ... first EPA-registered antimicrobial solid touch surface to help protect ... reasonably priced surface that kills greater than 99.9% of ... exposure. 1 , ...
(Date:9/17/2014)... FRANCISCO, Calif. , Sept. 17, 2014 ... a molecular diagnostics company pioneering the field of molecular ... to chief operating officer. Mr. Hall joined ... the company,s commercial entry into endocrinology. Since 2012, he ... as well as managed care and billing functions. As ...
(Date:9/17/2014)... Beckman Coulter , a global ... has renewed its agreement with Personify for ... agreement, Personify will continue to streamline the Beckman Coulter ... analytics, including time-to-fill, time-to-source and a deep reduction to ... Personify was based on the success of our partnership ...
(Date:9/17/2014)... September 17, 2014 NASA’s MESSENGER has ... Engineering Corporation is proud to have one of its ... MESSENGER mission is a scientific investigation of the planet ... be sent there, and has provided a vast amount ... V27200 family of latch valves utilize solenoids that also ...
Breaking Biology Technology:Innovative Gilmour Academy Ice Arena changes more than 200 fixtures to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 2Innovative Gilmour Academy Ice Arena changes more than 200 fixtures to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 3Veracyte, Inc. Announces Promotion of Christopher M. Hall To Chief Operating Officer 2Veracyte, Inc. Announces Promotion of Christopher M. Hall To Chief Operating Officer 3Veracyte, Inc. Announces Promotion of Christopher M. Hall To Chief Operating Officer 4Beckman Coulter Signs 3-year RPO Contract with Personify 2Beckman Coulter Signs 3-year RPO Contract with Personify 3
... Regulus Therapeutics Inc ., a biopharmaceutical company leading the ... announced that it has identified a third microRNA target ... milestone payment from GSK. This selection represents another significant ... which is focused on the discovery and development of ...
... , Daval International announced the ... double blind Phase II,Study, Treating Patients with Bladder ... Standard clinical,measures and assessment scores recorded on patients ... be used to investigate safety,efficacy and response to ...
... ReSearch Pharmaceutical Services, Inc. (RPS), a next ... clinical development solutions to the biopharmaceutical and medical ... to its Operational and Senior Management team.   ... Chief Information Officer and Executive Vice President, Clinical ...
Cached Biology Technology:Regulus Therapeutics and GlaxoSmithKline Name a Third Alliance microRNA Target Triggering a Preclinical Milestone Payment 2Regulus Therapeutics and GlaxoSmithKline Name a Third Alliance microRNA Target Triggering a Preclinical Milestone Payment 3Regulus Therapeutics and GlaxoSmithKline Name a Third Alliance microRNA Target Triggering a Preclinical Milestone Payment 4Daval International Announces Completion of Phase II Trial for the Treatment of Bladder Dysfunction With AIMSPRO® in Secondary Progressive Multiple Sclerosis 2Daval International Announces Completion of Phase II Trial for the Treatment of Bladder Dysfunction With AIMSPRO® in Secondary Progressive Multiple Sclerosis 3RPS Continues Expansion of Global Clinical, Regulatory, Medical, and Operational Leadership 2RPS Continues Expansion of Global Clinical, Regulatory, Medical, and Operational Leadership 3
(Date:9/17/2014)... of Oncology-Bellvitge Biomedical Research Institute (ICO-IDIBELL), led by ... in normal accompanying cells in colorectal tumors. Analysis ... colorectal tumors, predict the evolution of the patient ... relapses. , Biomarkers , Colorectal ... considering both sexes. About 30,000 new cases are ...
(Date:9/17/2014)... growing significantly faster since the 1960s. The typical development ... they have accelerated -- by as much as 70 ... out by scientists from Technische Universitt Mnchen based on ... continuously observed since 1870. Their findings were published recently ... "forest dieback" was a hot topic, with the very ...
(Date:9/16/2014)... The risk of severe maternal morbidity amongst women ... suggests a new study published today (17 September) ... and Gynaecology . , Australians generally enjoy high ... that health disparities exist, in particular between indigenous ... aimed to explore the independent impact of socioeconomic ...
Breaking Biology News(10 mins):Five genes to predict colorectal cancer relapses 2Global change: Trees continue to grow at a faster rate 2Global change: Trees continue to grow at a faster rate 3New study examines the impact of socioeconomic position & maternal morbidity in Australia 2New study examines the impact of socioeconomic position & maternal morbidity in Australia 3
... investigated the rates of evolution of the two key characteristics ... order to fly, hulking meat-eating dinosaurs had to shrink in ... wings. "We were really surprised to discover ... at the origin of Paraves," said Mr Puttick of Bristol,s ...
... subtype of innate lymphoid cells in human spleen essential ... the prestigious journal Nature Immunology , clears the ... more efficient vaccines against encapsulated bacteria, considered highly virulent., ... research group at IMIM (Institut Hospital del Mar d,Investigacions ...
... discovered a ,microbial Pompeii, preserved on the teeth of ... discovery is the dental calculus (plaque) which preserves bacteria ... teeth, effectively creating a mineral tomb for microbiomes. ... oral cavity carries numerous opportunistic pathogens and that periodontal ...
Cached Biology News:New insights into the origin of birds 2Researchers have identified a novel immunological mechanism of great importance for vaccine developm 2Scientists unlock a 'microbial Pompeii' 2Scientists unlock a 'microbial Pompeii' 3
TEMPLIPHI HT SEQ AMPL KIT, 1 EA. Category: Sequencing Template Amplification....
This Malachite Green Phosphate Detection Kit...
Request Info...
1+ mg expected yield of purified protein, expressed in insect cells - excludes cDNA...
Biology Products: